Capital Research Global Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17B | Buy |
4,414,621
+1,499,720
| +51% | +$814M | 0.34% | 67 |
|
|
2025
Q4 | $1.69B | Sell |
2,914,901
-247,761
| -8% | -$140M | 0.31% | 70 |
|
|
2025
Q3 | $1.53B | Sell |
3,162,662
-2,270,997
| -42% | -$1.06B | 0.29% | 82 |
|
|
2025
Q2 | $2.2B | Sell |
5,433,659
-2,179,138
| -29% | -$911M | 0.44% | 52 |
|
|
2025
Q1 | $3.79B | Sell |
7,612,797
-307,929
| -4% | -$167M | 0.82% | 33 |
|
|
2024
Q4 | $4.12B | Sell |
7,920,726
-266,957
| -3% | -$147M | 0.85% | 30 |
|
|
2024
Q3 | $5.06B | Sell |
8,187,683
-49,611
| -0.6% | -$29.4M | 1.05% | 23 |
|
|
2024
Q2 | $4.56B | Buy |
8,237,294
+124,157
| +2% | +$71.1M | 1% | 22 |
|
|
2024
Q1 | $4.72B | Buy |
8,113,137
+123,523
| +2% | +$69.3M | 1.07% | 22 |
|
|
2023
Q4 | $4.24B | Buy |
7,989,614
+517,137
| +7% | +$250M | 1.04% | 23 |
|
|
2023
Q3 | $3.78B | Buy |
7,472,477
+1,381,152
| +23% | +$736M | 1.04% | 26 |
|
|
2023
Q2 | $3.18B | Buy |
6,091,325
+157,512
| +3% | +$85M | 0.85% | 28 |
|
|
2023
Q1 | $3.42B | Sell |
5,933,813
-1,224,453
| -17% | -$690M | 0.98% | 26 |
|
|
2022
Q4 | $3.94B | Sell |
7,158,266
-1,598,526
| -18% | -$847M | 1.19% | 15 |
|
|
2022
Q3 | $4.44B | Buy |
8,756,792
+12,258
| +0.1% | +$6.86M | 1.46% | 13 |
|
|
2022
Q2 | $4.75B | Buy |
8,744,534
+55,023
| +0.6% | +$30.3M | 1.48% | 15 |
|
|
2022
Q1 | $5.13B | Sell |
8,689,511
-764,521
| -8% | -$439M | 1.27% | 16 |
|
|
2021
Q4 | $6.31B | Buy |
9,454,032
+208,075
| +2% | +$130M | 1.39% | 12 |
|
|
2021
Q3 | $5.28B | Buy |
9,245,957
+185,462
| +2% | +$102M | 1.23% | 16 |
|
|
2021
Q2 | $4.57B | Buy |
9,060,495
+205,674
| +2% | +$97M | 1.06% | 22 |
|
|
2021
Q1 | $4.04B | Sell |
8,854,821
-1,081,065
| -11% | -$516M | 0.99% | 23 |
|
|
2020
Q4 | $4.63B | Sell |
9,935,886
-1,641,495
| -14% | -$770M | 1.2% | 18 |
|
|
2020
Q3 | $5.11B | Sell |
11,577,381
-84,968
| -0.7% | -$35.1M | 1.53% | 13 |
|
|
2020
Q2 | $4.23B | Sell |
11,662,349
-124,307
| -1% | -$41.7M | 1.34% | 14 |
|
|
2020
Q1 | $3.34B | Sell |
11,786,656
-10,404
| -0.1% | -$3.28M | 1.31% | 15 |
|
|
2019
Q4 | $3.83B | Sell |
11,797,060
-237,594
| -2% | -$72M | 1.15% | 20 |
|
|
2019
Q3 | $3.51B | Sell |
12,034,654
-825,981
| -6% | -$237M | 1.15% | 20 |
|
|
2019
Q2 | $3.78B | Sell |
12,860,635
-1,804,915
| -12% | -$497M | 1.2% | 18 |
|
|
2019
Q1 | $4.01B | Sell |
14,665,550
-1,264,804
| -8% | -$315M | 1.27% | 20 |
|
|
2018
Q4 | $3.57B | Buy |
15,930,354
+38,359
| +0.2% | +$9M | 1.24% | 18 |
|
|
2018
Q3 | $3.88B | Sell |
15,891,995
-2,722,861
| -15% | -$626M | 1.13% | 21 |
|
|
2018
Q2 | $3.86B | Sell |
18,614,856
-216,590
| -1% | -$46M | 1.05% | 25 |
|
|
2018
Q1 | $3.89B | Sell |
18,831,446
-693,055
| -4% | -$145M | 1.11% | 21 |
|
|
2017
Q4 | $3.71B | Buy |
19,524,501
+1,097,165
| +6% | +$210M | 1.09% | 22 |
|
|
2017
Q3 | $3.49B | Buy |
18,427,336
+1,122,439
| +6% | +$203M | 1.05% | 24 |
|
|
2017
Q2 | $3.02B | Buy |
17,304,897
+3,973,136
| +30% | +$667M | 0.95% | 27 |
|
|
2017
Q1 | $2.05B | Sell |
13,331,761
-812,805
| -6% | -$124M | 0.65% | 45 |
|
|
2016
Q4 | $2B | Sell |
14,144,566
-289,036
| -2% | -$42.6M | 0.65% | 43 |
|
|
2016
Q3 | $2.3B | Sell |
14,433,602
-1,621,098
| -10% | -$250M | 0.76% | 34 |
|
|
2016
Q2 | $2.37B | Sell |
16,054,700
-496,300
| -3% | -$73.3M | 0.81% | 33 |
|
|
2016
Q1 | $2.34B | Sell |
16,551,000
-862,000
| -5% | -$116M | 0.81% | 34 |
|
|
2015
Q4 | $2.47B | Sell |
17,413,000
-665,000
| -4% | -$88.7M | 0.85% | 32 |
|
|
2015
Q3 | $2.21B | Buy |
18,078,000
+401,300
| +2% | +$52.3M | 0.79% | 32 |
|
|
2015
Q2 | $2.29B | Buy |
17,676,700
+743,800
| +4% | +$97M | 0.75% | 35 |
|
|
2015
Q1 | $2.27B | Buy |
16,932,900
+939,700
| +6% | +$121M | 0.78% | 29 |
|
|
2014
Q4 | $2B | Buy |
15,993,200
+96,300
| +0.6% | +$11.7M | 0.68% | 35 |
|
|
2014
Q3 | $1.93B | Sell |
15,896,900
-18,400
| -0.1% | -$2.24M | 0.67% | 34 |
|
|
2014
Q2 | $1.88B | Buy |
15,915,300
+899,000
| +6% | +$106M | 0.66% | 36 |
|
|
2014
Q1 | $1.81B | Buy |
15,016,300
+3,170,624
| +27% | +$377M | 0.65% | 37 |
|
|
2013
Q4 | $1.32B | Buy |
11,845,676
+1,121,376
| +10% | +$112M | 0.49% | 57 |
|
|
2013
Q3 | $988M | Buy |
10,724,300
+2,157,000
| +25% | +$195M | 0.39% | 72 |
|
|
2013
Q2 | $725M | Buy |
+8,567,300
| New | +$713M | 0.31% | 91 |
|
Other funds holding TMO
VCM
Capital Research Global Investors's TMO Position: Q1 2026 in Review
Capital Research Global Investors increased its Thermo Fisher Scientific (TMO) stake by 51% in Q1 2026, buying an estimated $814M and bringing the position to 4,414,621 shares worth $2.17B. The position accounts for 0.34% of the portfolio, ranked #67.
Capital Research Global Investors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.31B in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Capital Research Global Investors held 4,414,621 shares of Thermo Fisher Scientific worth $2.17B as of Q1 2026.
- Capital Research Global Investors bought 1,499,720 Thermo Fisher Scientific shares in Q1 2026, an estimated $814M.
- Thermo Fisher Scientific made up 0.34% of Capital Research Global Investors's portfolio in Q1 2026, its #67 holding.
- Capital Research Global Investors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Capital Research Global Investors's Thermo Fisher Scientific position peaked at $6.31B in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.